drugset / Trial / NCT03215940

Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)

NCT03215940

Phase 0 Completed 53 enrolled University of Utah
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a study comparing the effects of Delta-9-Tetrahydrocannabinol (THC) versus Cannabidiol (CBD) versus a placebo on chronic non-cancer pain.

Timeline

Start
2018-02-01
Primary completion
2024-12-01
Completion
2024-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cannabidiol Other / unclassified Oral
Comparator delta-9-tetrahydrocannabinol Other / unclassified Oral

Indications